The maker of the world's best-selling diabetes drug is facing hundreds of lawsuits and likely a big sales drop as suspicion grows that taking the pill for more than a year raises the risk of bladder cancer.
In June, Takeda Pharmaceuticals Co. Ltd. halted sales of Actos, its top drug, in Germany and France after pressure from regulators.
Since then, both the U.S. Food and Drug Administration and the European Medicines Agency have issued warnings about the cancer risk based on new research, but they have allowed sales to continue. Doctors are being told not to prescribe Actos for people who have or have had bladder cancer.
'I could lose my bladder and possibly need chemo.'— Nancy RiosIn June, Health Canada said Canadian product material for Actos already includes post-marketing reports of bladder cancer that have been reported very rarely with the use of the drug, adding the department continues to monitor safety of the drug, also called pioglitazone.
Saturday, August 06, 2011
Diabetes drug Actos clouded in lawsuits - Health - CBC News
via cbc.ca
Subscribe to:
Post Comments (Atom)
1 comment:
Eli Lilly Zyprexa can *cause* diabetes.
I took Zyprexa a powerful Lilly schizophrenic drug for 4 years it was prescribed to me off-label for post traumatic stress disorder was ineffective costly and gave me diabetes.
Eli Lilly's #1 cash cow Zyprexa drug sale $40 billion dollars so far,has a ten times greater risk of causing type 2 diabetes over the non-user of Zyprexa. So,here we have a conflict of interest that this same company also is a big profiteer of diabetes treatment.
-- Daniel Haszard http://www.zyprexa-victims.com
Eli Lilly makes Actos how about that?
Post a Comment